Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.34 USD
Change Today -0.04 / -10.53%
Volume 20.6K
OVIT On Other Exchanges
As of 8:10 PM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

oncovista innovative therapi (OVIT) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/19/15 - $1.16
52 Week Low
12/18/14 - $0.0066
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

oncovista innovative therapi (OVIT) Related Businessweek News

No Related Businessweek News Found

oncovista innovative therapi (OVIT) Details

OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. Its drug candidate pipeline includes Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of Refractory TdT Positive Leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of Colon Cancer. The company was founded in 2004 and is based in San Antonio, Texas.

2 Employees
Last Reported Date: 08/14/15
Founded in 2004

oncovista innovative therapi (OVIT) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $310.0K
Compensation as of Fiscal Year 2014.

oncovista innovative therapi (OVIT) Key Developments

OncoVista Mulls Strategic Alternatives

OncoVista Innovative Therapies, Inc. (OTCPK:OVIT) continues to work with its financial advisor, Great Plains Capital Partners, LLC, in assessing merger and acquisition opportunities and other strategic alternatives that would add greater value to the portfolio.

Oncovista Innovative Therapies, Inc. Settles 3 Year Litigation in New York Supreme Court

Oncovista Innovative Therapies, Inc. announced its 3 year litigation has been settled favorably in the New York Supreme Court.

OncoVista Innovative Therapies, Inc. announced delayed annual 10-K filing

On 03/23/2015, OncoVista Innovative Therapies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OVIT:US $0.34 USD -0.04

OVIT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OVIT.
View Industry Companies

Industry Analysis


Industry Average

Valuation OVIT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ONCOVISTA INNOVATIVE THERAPI, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at